The topic of death is often a sensitive and somber one, but it is also a reality that we must face. When someone passes away, there are many legal
considerations that come into play surrounding their assets, property, and final wishes.
Before delving into the specifics, you must first understand that laws and regulations surrounding death and inheritance can vary greatly depending on location.
Different countries, states, and even cities may have their own unique set of laws and procedures in place. involved. That's why you need a legal overview to
guide you through the process of protecting your rights in the case of death.
Wrongful Death Lawsuits and Compensation
In the unfortunate event of a wrongful death, where a person dies due to the negligence or misconduct of another, the bereaved family may seek compensation
through legal action. Hiring a lawyer for wrongful death is the best course of action to navigate the complex legal process and ensure that your rights are
protected. Wrongful death lawsuits can cover a wide range of incidents, from car accidents to medical malpractice. The compensation awarded in these cases may
include funeral expenses, lost wages, and loss of companionship. Know that each case is unique and the amount of compensation awarded will depend on the
deceased's income and potential earnings, their age, and the extent of their financial support to their dependents.
In 2023, almost 14,000 people in England are estimated to have died due to excessive waits in emergency departments, averaging more than 260 deaths per week,
according to new figures from the Royal College of Emergency Medicine (RCEM).
The RCEM estimate is based on a large study of NHS patients published in the Emergency Medicine Journal in 2021, which found one excess death for every 72 patients
who spent eight to 12 hours in an A&E department.
Following a Freedom of Information audit of NHS trusts, the college has found that 65 per cent of people waiting 12 hours or more in A&E were patients waiting for
a hospital bed.
NHS data for England revealed that over 1.5 million patients waited 12 hours or more in major emergency departments last year. Based on the RCEM calculation, this
indicates that over a million of those patients were waiting for a bed.
The UK's Health Security Agency (UKHSA) said mistakes at a testing laboratory led to misreporting of tens of thousands of positive COVID-19 cases as negative
and may have resulted in the deaths of about 20 people.
Britain has one of the highest coronavirus death tolls in the world, with more than 177,000 deaths since the pandemic started in 2020.
Many experts have said the contact tracing programme fell well short of the "world-beating" system the government had promised.
An investigation by the government agency responsible for responding to public health emergencies said the Immensa laboratory in central England was found to have
misreported around 39,000 tests as negative when they should have been positive between September 2 and October 12 last year.
Community pharmacies are well placed to play a role in preventing deaths from cardiovascular disease (CVD) said Director of NHS Services.
The recent analysis by the British Heart Foundation (BHF) revealed that nearly 100,000 more people with cardiovascular disease than expected have died since the
start of the pandemic in England.
Latest figures show that the number of people waiting for time-sensitive cardiac care was at a record high of nearly 390,000 at the end of April in England.
Average ambulance response times for heart attacks and strokes have consistently been above 30 minutes since the beginning of 2022, and in December 2022 they even
breached 90 minutes. The target is 18 minutes, though the Government has set a new average target of 30 minutes over 2023/24.
Director of NHS Services, Alastair Buxton, said: "It is concerning to hear that there have been tens of thousands of preventable deaths from cardiovascular
disease (CVD) since the start of the COVID-19 pandemic. We share BHF's desire to see more action on preventing the causes of CVD and, subject to appropriate
funding being in place, community pharmacy teams are well placed to play a role in this.
The Taskforce report recognises the important role of community pharmacy and pharmacy teams, and in particular, the fact that they often have most contact with
individuals who are receiving medication assisted treatment, commented the Royal Pharmaceutical Society (RPS) on the publication of the Scottish Drug Deaths
Taskforce's final report.
The final report published on Thursday (June 21) follows four years of work developing and implementing a programme of actions to tackle the rising number of drug
deaths in Scotland.
RPS, as pharmacy's professional leadership body in Scotland and the rest of Great Britain, has positively engaged with the Taskforce as it carried out its work.
Last year, RPS published 'Pharmacy's role in reducing harm and preventing drugs deaths (Scotland)' which contained 14 key recommendations. Many of the recommended actions within the Taskforce's report align with RPS policy.
Long waits for an ambulance or surgery led to the death of 112 people, and nearly 8,000 more people suffered harm while waiting for help in England last year.
The data from NHS England, obtained by The Guardian, show that patient deaths arising directly from care delays have risen more than fivefold over the last
three years.
In 2019, there were 21 patient deaths due to NHS care delays, and 96 people suffered "severe harm" as compared to 152 last year.
Adult mental health care was mostly affected with 471 patients experiencing harm due to delays, followed by childbirth care (253), eye problems (221), and
trauma and general surgery (207).
There has been increase of 97 percent in the overall number of people suffering some degree of harm, from 3,979 in 2019 to 7,856 in 2022.
A Labour Party analysis of NHS trust figures has revealed that around 148,000 people died last year while waiting for treatment in England.
This is more than double the figure recorded in 2017/18, which stood at around 60,000 deaths. It even surpasses the mortality rate observed in 2021, during
the peak of the Covid pandemic.
The Labour Party obtained the data through a freedom of information request sent to every NHS trust in England. Out of the 169 acute and community trusts
contacted, 80 responded.
The total number of deaths reported by the respondents was 61,396. Extrapolating this figure to all trusts would suggest a total of 148,227 deaths.
The government has launched the Global AMR Innovation Fund (GAMRIF) on Monday (22 May), under which it has announce up to £39 million fund for antimicrobial
resistance (AMR) research.
Of this new funding package, up to £24 million over four years has been awarded to bolster the UK's partnership with CARB-X - a global AMR research initiative - to
support the continued early development of invaluable new antibiotics, vaccines, rapid diagnostics and other products to combat life threatening drug-resistant
infections and prevent death and disease across the world.
In addition to the CARB-X grant, GAMRIF is investing £5 million over two years into the Global Antibiotic R&D Partnership (GARDP) to develop - and ensure global
access to - new antibiotic treatments against major global health priorities.
The announcement comes as Health Minister Will Quince attends the World Health Assembly (WHA) in Geneva, Switzerland, and Development Minister Andrew Mitchell
participates in an event on health leadership and climate change alongside the WHA. They will announce the launch of the UK government's Global Health Framework for
2023-2025, as part of Minister Quince's address at the WHA.
Health Minister Will Quince said: Antimicrobial resistance is a major threat to global health and has led to millions of tragic deaths per year, but the Global AMR
Innovation Fund is supporting cutting-edge research and developing vital new treatments to prevent death and disease across the world.
India will make tests mandatory for cough syrups before they are exported, a government notice showed on Tuesday, after Indian-made cough syrups were linked
to the deaths of dozens of children in Gambia and Uzbekistan.
Any cough syrup must have a certificate of analysis issued by a government laboratory before it is exported, effective June 1, the government said in a notice dated
May 22 and shared by the health ministry on Tuesday.
India's $41 billion pharmaceutical industry is one of the biggest in the world but its reputation was shaken after the World Health Organization (WHO) found toxins
in cough syrups made by three Indian companies.
Syrups made by two of these companies were linked to the deaths of 70 children in Gambia and 19 in Uzbekistan last year.
"Cough syrup shall be permitted to be exported subject to the export sample being tested and production of certificate of analysis," said the notice issued by the
trade ministry.
The health ministry did not immediately respond to a query on whether testing would be required for cough syrups sold in the domestic market.
Scottish community pharmacies will now hold two Naloxone kits, available in either nasal spray or injectable form, essential for reversing opioid overdoses.
The Emergency Access Naloxone Scheme, which is backed by £300,000 of Scottish Government funding, began on Monday (30 October).
Drugs and Alcohol Policy Minister Elena Whitham said, "Through our National Mission to reduce drug deaths and harms, we have invested more than £3 million in
widening access to Naloxone, including through our emergency services."
Witham said this new nationwide service is a welcome addition to existing services. "Police Scotland recently completed a force-wide rollout to 12,500 officers
who have used the kits more than 300 times. According to the most recent statistics, 70 per cent of those who are at risk of opioid overdose are being provided
with a lifesaving kit," she added.
"It provides a substantial increase in life-saving emergency access and I'm grateful to all those in community pharmacies who are supporting our £250 million
National Mission to reduce drug deaths," Whitham said.
Two new subvariants of Omicron - BA.4 and BA.5 - are spreading much faster than other corovanirus variants in Europe, which could lead to more hospitalisations
and deaths as they become dominant, the EU's disease prevention agency said on Monday (June 13).
Most EU countries have so far detected low rates of the two subgroups. But in countries where the proportion has risen - such as Portugal, where BA.5 accounted for
87 per cent of cases by May 30 - there have been surges in overall cases, according to the European Centre for Disease Prevention and Control (ECDC).
The two sublineages were added to the World Health Organization's monitoring list in March and have also been designated as variants of concern by the ECDC.
Variants BA.4 and BA.5 do not appear to carry a higher risk of severe disease than other forms of Omicron.But an increase in case numbers from higher transmission
rates risks leading to an increase in hospitalisations and deaths, the agency said.
"The growth advantage reported for BA.4 and BA.5 suggest that these variants will become dominant," ECDC said in a statement on its website.
Deaths caused by hepatitis C has declined by 35 per cent in England between 2015 and 2020, latest data from the UK Health Security Agency (UKHSA) revealed.
It showed that estimated prevalence of chronic hepatitis C in England has continued to fall to around 81,000 in 2020 from 129,000 in 2015, showing a considerable progress has been made towards eliminating the virus as a public health problem by 2030 in England.
Commenting on the data release, health and social care secretary Sajid Javid, said: "It is fantastic to see the significant progress that has been made in eliminating hepatitis C in England. Deaths and prevalence of the virus have fallen consistently thanks to improvements in diagnosis, access to treatments and the hard work of the NHS.
"This is another example of the UK being at the forefront of tackling serious diseases. We are on track to eliminate this virus by 2030 and I urge anyone who may be at risk to get tested as soon as possible."
A total of 7,599 whooping cough cases have been recorded in England from January to May 2024, according to new data released by the UK Health Security Agency
(UKHSA).
In January 2024, there were 555 cases, followed by 920 in February, 1,427 in March, 2,106 in April, and 2,591 in May.
While the majority of cases (over 53 per cent) occurred in individuals aged 15 years or older, who typically experience milder symptoms, a significant number (262)
were reported in babies under 3 months old, who are at the highest risk of severe complications and death from whooping cough.
Since the outbreak began in November last year, there have been nine infant deaths (one in December 2023 and eight between January and May 2024).
Whooping cough, or pertussis, is a bacterial infection affecting the lungs. This cyclical disease peaks every 3 to 5 years, with the last increase seen in 2016.
Queen Elizabeth II, Britain's longest-reigning monarch, the nation's figurehead and a towering presence on the world stage for seven decades, died peacefully
at her home in Scotland on Thursday aged 96.
"The death of my beloved Mother, Her Majesty The Queen, is a moment of the greatest sadness for me and all members of my family," the new king, her eldest son Charles,
said.
"I know her loss will be deeply felt throughout the country, the Realms and the Commonwealth, and by countless people around the world," the 73-year-old said in a
statement.
The news has stunned and deeply saddened community pharmacy in Britain.
The Pharmaceutical Services Negotiating Committee (PSNC) issued a statement to say it "has been very saddened to hear of the death of Her Majesty the Queen.
"At this time of national mourning, we join the rest of the country in sending our thoughts and condolences to the royal family."
A new study has revealed that the risk of death from COVID-19 decreases significantly after vaccination, but this protection diminishes after six months,
providing evidence for continued booster doses.
Researchers from the UK Health Security Agency (UKHSA), who analysed more than 10 million cases of COVID-19 in adults in England between May 2020 and February
2022, found a clear association between vaccination and reduced mortality.
But they also highlighted a crucial timeframe - within six months of the last vaccine dose - when Case Fatality Risk (CFR) - the proportion of cases that resulted
in death - was consistently at its lowest across all age groups. After this, the protective benefit of the vaccine began to wane and CFR increased.
The outbreak of Burkholderia cepacia complex (Bcc) in the UK, which is associated with contaminated eye gels imported from India, has led to the death of
one person, and many others falling ill, according to a government report.
Bcc is a group of antibiotic-resistant bacteria that are widely found within the environment. Although it rarely causes infection, it can result in severe ones in
individuals with compromised immune systems and those living with cystic fibrosis, the UK Health Security Agency (UKHSA) said.
Between January 2023 and February 2024, there were 52 confirmed and six probable cases across the UK linked to the bacteria outbreak, as revealed in the Health
Protection Report published by UKHSA.
Forty-one of these cases were hospital inpatients, 38 of which were in critical-care settings.
Twenty-five cases were considered to have "clinically significant infections attributable to Bcc", out of which 11 had eye infections, nine had respiratory
infections and four had bacteremia (bacteria entering the bloodstream).
Two individuals with cystic fibrosis (CF) were infected, and while one was treated, the other died, with the report indicating Bcc infection to have "contributed
to the death."
Breast cancer is a global epidemic and is the second leading cause of cancer related deaths in women around the globe, however the death rate varies but there is hardly any country in which this disease is not identified as the disease of women world. Women are strongly advised to struggle for …
ScienceDaily (Mar. 11, 2009) - For every gram of salt that Americans reduce in their diets daily, a quarter of a million fewer new heart disease cases and over 200,000 fewer deaths would occur over a decade, researchers said at the American Heart Association's 49th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.
Folding Lightweight Wheelchairs
For indoor wheelchair safety the folding power wheelchair models that are lightweight have front casters which turn easily, making them ideal for use in small apartments. Having the casters in front makes this a dangerous chair to use outdoors as the front wheels can turn sharply if encountering a crack in the sidewalk, incline, or rocks.Wheelchair india is manufacturer, supplier, distributor and dealer of Karma KP 10-2 Power Wheelchair for disabled and handicapped in india.
They usually have one or two removable batteries and have a similar appearance as the manual wheelchair. They can be controlled with a joystick or a sip and puff method.
Lightweight Power Assisted Wheelchairs
These chairs can be propelled in a similar manner as the manual wheelchair or use a battery. You may want this type if you want to keep fit and get some exercise but need some power when going up an incline or when traveling a distance. They are smaller and lighter weight than the folding wheelchair and have smaller batteries and motors.
Dual Purpose Power Wheelchairs
These chairs generally are good for either indoor or outdoor use. You need to have larger wheels in front for outdoors as this is a safety feature. It is better to have six wheels for stability when traveling outdoors.
These indoor/outdoor power chairs compromise wheelchair safety and perform poorly when you do not have enough room to turn indoors and you need to travel over rough ground and uneven surfaces.
Their optimum performance indoors is when you have wider doors and hallways in assisted living facilities, nursing homes, or homes/apartments. Ideal outdoor surfaces in urban and suburban areas would include sidewalks and paved areas.
Outdoor Power Wheelchairs
These chairs weigh as much as 400-500 pounds, add the weight of the user up to 250 pounds and the total weight is approximately 650 pounds. They are very efficient outdoors with their rear wheels they can sa